Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HORIZON-1 phase 3 study of zovaglutide in adults with overweight or obesity
CTR20254265Phase 3Active
- Sponsor
- Quality Peptide
- Start
- Jan 2026
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of zovaglutide in Overweight, obesity, sponsored by Quality Peptide. Started Jan 2026; status: active.
02
Drugs
zovaglutide
03
Conditions
Overweightobesity
Beyond the preview
Go deeper on CTR20254265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20254265.